Clinical Trial Update: Pharmacological Modulation of Hippocampal Activity in Psychosis 2 [Phase 2]

View source ↗

Summary

Phase 2 trial assessing pharmacological modulation of hippocampal activity for schizophrenia/psychosis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis
• Schizophrenia

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Schizophrenia; Psychosis | Phase 2 | Status: COMPLETED | Results posted: 2024-02-05